These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16462645)

  • 1. [Treatment of major depressive disorder. Comorbidity, depression and anxiety: dangerous liaisons].
    Vanelle JM
    Encephale; 2005 Dec; 31 Pt 3():S34-5; discussion S37. PubMed ID: 16462645
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Treatment of perinatal mood and anxiety disorders: a review.
    Magalhães PV; Pinheiro RT
    Can J Psychiatry; 2008 Mar; 53(3):209; author reply 210. PubMed ID: 18441668
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Treatment of perinatal mood and anxiety disorders: a review.
    Devarajan S; Devarajan K; Dursun S
    Can J Psychiatry; 2008 Mar; 53(3):209-10; author reply 210. PubMed ID: 18444281
    [No Abstract]   [Full Text] [Related]  

  • 4. The comorbidity of anxiety and depression.
    Rodney J; Prior N; Cooper B; Theodoros M; Browning J; Steinberg B; Evans L
    Aust N Z J Psychiatry; 1997 Oct; 31(5):700-3. PubMed ID: 9400876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical inquiries. How should we treat major depression combined with anxiety?
    Trotter B; Kelsberg G; St Anna L; Lo V
    J Fam Pract; 2007 Apr; 56(4):306-8. PubMed ID: 17403330
    [No Abstract]   [Full Text] [Related]  

  • 6. ECNP Consensus Meeting March 2000. Guidelines for investigating efficacy in GAD.
    Montgomery D;
    Eur Neuropsychopharmacol; 2002 Feb; 12(1):81-7. PubMed ID: 11788245
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting treatment in patients with mixed symptoms of anxiety and depression.
    Fawcett J
    J Clin Psychiatry; 1990 Nov; 51 Suppl():40-3. PubMed ID: 1977742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antidepressant use between subjects with bipolar disorder and major depressive disorder with or without comorbid anxiety.
    Schaffer A; Cairney J; Veldhuizen S; Cheung A; Levitt A
    J Clin Psychiatry; 2007 Nov; 68(11):1785-92. PubMed ID: 18052573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and therapeutic characteristics of social phobia in French psychiatry (Phoenix study)].
    Pélissolo A; Huron C; Fanget F; Servant D; Stiti S; Richard-Berthe C; Boyer P
    Encephale; 2006; 32(1 Pt 1):106-12. PubMed ID: 16633297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary: defining remission in patients treated with antidepressants.
    Thase ME
    J Clin Psychiatry; 1999; 60 Suppl 22():35-6. PubMed ID: 10634354
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidepressants: the blue-chip psychotropic for the modern treatment of anxiety disorders.
    Stahl SM
    J Clin Psychiatry; 1999 Jun; 60(6):356-7. PubMed ID: 10401911
    [No Abstract]   [Full Text] [Related]  

  • 12. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.
    Schaffer A; McIntosh D; Goldstein BI; Rector NA; McIntyre RS; Beaulieu S; Swinson R; Yatham LN;
    Ann Clin Psychiatry; 2012 Feb; 24(1):6-22. PubMed ID: 22303519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing onset of treatment benefit in depression and anxiety: conceptual considerations.
    Laska EM; Mallinckrodt CH; Mundt JC; Leber P; Vaccarino AL; Kalali AH; Greist JH
    J Clin Psychiatry; 2009 Aug; 70(8):1138-45. PubMed ID: 19758524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment anxiety predicts patterns of change in cognitive behavioral therapy and medications for depression.
    Forand NR; Derubeis RJ
    J Consult Clin Psychol; 2013 Oct; 81(5):774-82. PubMed ID: 23647285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: the GADIS II study (Generalized Anxiety and Depression Impact Survey II).
    Ansseau M; Fischler B; Dierick M; Albert A; Leyman S; Mignon A
    Depress Anxiety; 2008; 25(6):506-13. PubMed ID: 17595015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute reduction in anxiety after deep transcranial magnetic stimulation (DTMS) in unipolar major depression- a systematic review and meta-analysis.
    Kedzior KK; Gellersen HM; Roth Y; Zangen A
    Psychiatry Res; 2015 Dec; 230(3):971-4. PubMed ID: 26616303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].
    Pélissolo A; André C; Chignon JM; Dutoit D; Martin P; Richard-Berthe C; Tignol J
    Encephale; 2002; 28(6 Pt 1):510-9. PubMed ID: 12506263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression.
    Barbee JG; Billings CK; Bologna NB; Townsend MH
    J Affect Disord; 2003 Feb; 73(3):229-36. PubMed ID: 12547291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling anxiety and depression.
    Mynatt S; Cunningham P
    Nurse Pract; 2007 Aug; 32(8):28-36; CEU quiz 36-7. PubMed ID: 17667764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.